Inotropic augmentation of myocardial oxygen consumption.
D000818:Animals; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology*; D010101:Oxygen Consumption; D011799:Quinazolines / Q000494:pharmacology*; D012039:Regional Blood Flow; D013328:Strophanthins / Q000494:pharmacology*
D011799:Quinazolines; D013328:Strophanthins; D009638:Norepinephrine